Brainstorm Cell Therapeutics Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-3.9M | $-2.1M | $-2.4M | $-2.1M | $-2.9M | $-2.9M | $-3.0M | $-2.7M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $46.0K | $37.0K | $48.0K | $48.0K | $51.0K | $52.0K | $53.0K | $59.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | $143.0K | $660.0K | $0 | $717.0K | $156.0K | $178.0K |
| Net Cash from Operating Activities | $-895.0K | $-1.3M | $-740.0K | $-1.1M | $-3.5M | $-1.6M | $-1.0M | $-3.3M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $898.0K | $1.3M | $780.0K | $313.0K | $2.7M | $3.1M | $1.1M | $0 |
| Net Change in Cash | $3.0K | $-70.0K | $40.0K | $-789.0K | $-801.0K | $1.5M | $22.0K | $-3.3M |
| Free Cash Flow | — | — | — | — | — | — | — | — |